will tirzepatide be available Mission Family Medicine launches in-clinic program New Pricing, Access to Tirzepatide

Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists

[1] [2] Blood levels of B12 may rise quickly following injection, though elevated blood levels do not immediately translate to symptom resolution

The problem has never been the molecule

What does a good support routine look like